/PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics...
North America Legal Cannabis Industry Report 2024: Market globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reaffirmed their buy rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $60.00 price objective on the stock. LBPH has been the topic of a number of other reports. Guggenheim increased their price objective on […]
Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
The U.S. Federal Trade Commission warned hundreds of companies including Pfizer Inc., Baxter International Inc. and Thermo Fisher Scientific Inc. that it could challenge their acquisitions even after ...
FTC warned Baxter about Hillrom deal | Crain's Chicago Business chicagobusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chicagobusiness.com Daily Mail and Mail on Sunday newspapers.
Pfizer, Thermo Fisher Among 200 Companies Warned by FTC Over Deals bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $20.11, but opened at $20.80. Longboard Pharmaceuticals shares last traded at $20.52, with a volume of 36,001 shares changing hands. Analyst Upgrades and Downgrades LBPH has been the topic of several analyst […]
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report)’s share price traded down 4.7% during trading on Thursday . The stock traded as low as $22.76 and last traded at $22.81. 48,819 shares were traded during mid-day trading, a decline of 98% from the average session volume of 2,009,614 shares. The stock had previously closed at […]
Analysts Set Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) PT at $36.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.